ARVN: the cash flow

MyFinsight

For the year ending 2025-12-31, ARVN had $42,400K increase in cash & cash equivalents over the period. -$275,700K in free cash flow.

Cash Flow	2025-12-31
Net loss	-80,800
Depreciation and amortization	3,000
Net accretion of bond discounts/premiums	12,800
Loss on sale of marketable securities	0
Amortization of right-of-use assets	2,200
Amortization of collaboration contract asset	4,300
Net loss on disposal of property, equipment and leasehold improvements	0
Stock-based compensation	44,000
Accounts receivable	-4,700
Other receivables	-2,600
Prepaid expenses and other assets	-5,300
Collaboration contract asset	0
Accounts payable and accrued liabilities	-1,700
Operating lease liabilities	-2,000
Deferred revenue	-242,600
Net cash used in operating activities	-273,800
Purchase of marketable securities	354,200
Maturities of marketable securities	731,100
Sale of marketable securities	32,600
Purchase of property, equipment and leasehold improvements	1,900
Proceeds from disposal of property, equipment and leasehold improvements	0
Net cash provided by investing activities	407,600
Repayments of long-term debt	200
Proceeds from issuance of common stock and pre-funded warrants	0
Payment of common stock offering costs	0
Repurchase of common shares, net	91,900
Proceeds from exercise of stock options and issuance of espp shares	700
Net cash (used in) provided by financing activities	-91,400
Net increase (decrease) in cash, cash equivalents and restricted cash	42,400
Cash, cash equivalents and restricted cash, beginning of the period	100,500
Cash, cash equivalents and restricted cash, end of the period	142,900

Unit: Thousand (K) dollars (except for numbers of shares and EPS).